Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Prof Nawangwe said Makerere University — ranked second in Africa and 63rd globally — continues to bolster its profile as a ...

The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...

Of the 3,185 new HIV cases recorded last year, 4.2% or 135 cases were detected among adolescents aged between 10 and 19, says ...

Cryo-EM revealed HIV-1 integrase’s distinct structures as it shifts between its two roles of DNA integration and RNA-binding.

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health ...

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...